SU5416 and Carboplatin to Treat Ovarian Cancer
NCT00006155
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
33
Enrollment
NIH
Sponsor class
Conditions
Fallopian Tube Neoplasm
Ovarian Cancer
Peritoneal Neoplasm
Interventions
DRUG:
SU5416 and carboplatin
Sponsor
National Cancer Institute (NCI)